Tudriqev - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

TikTok and ByteDance’s proposed $400 million US children’s privacy settlement faces a judicial hurdle over termination of a 2019 consent decree. Representative image.

TikTok’s $400m US privacy settlement hits judicial hurdle over 2019 consent decree

CXMT is reportedly preparing a NAND flash research and development production line in Beijing as the newly listed Chinese memory-chip company expands beyond DRAM. Representative image.

CXMT targets NAND flash as $8.6bn IPO gives China’s memory champion room to expand

Morgan Stanley’s North Haven Private Income Fund is working through another oversubscribed repurchase offer as private-credit liquidity demand remains elevated. Representative image.

Morgan Stanley private credit fund again gets withdrawal requests above its 5% limit

OpenAI reportedly expects hundreds of billions of dollars of negative free cash flow as it finances massive computing and data-centre expansion through 2030. Representative image.

OpenAI’s reported $278bn cash burn reveals the financing scale behind frontier AI

Amazon.com Inc and ASML Holding N.V. push 2026 tech layoffs past 26,000 as efficiency strategies take hold

Read More

Pharma Industry News

Replimune Group (NASDAQ: REPL) plans layoffs after FDA rejects Tudriqev again, forcing a biotech reset

Replimune plans layoffs after the FDA rejected Tudriqev again. Read what the setback means for REPL stock, cash runway, strategy, and rivals.

byPallavi Madhiraju

April 11, 2026

web analytics